Thursday, March 31, 2016

NIH Grant - Partnerships for Countermeasures Against Select Pathogens (R01)

This grant provides funding for milestone-driven preclinical research that will advance the development and/or production of lead therapeutics, vaccines or medical diagnostics for select Emerging Infectious Diseases/Pathogens. 

All projects must have investment by at least one industry participant. Industry means a pharmaceutical, biotechnology, bioengineering, or chemical company. 

The list of Emerging Infectious Diseases/Pathogens is here - https://www.niaid.nih.gov/topics/BiodefenseRelated/Biodefense/Pages/CatA.aspx. 

The list  includes  dengue, melioidosis, diarrheagenic E.coli and chikungunya virus.

Study can be in the areas of - 

Therapeutics

Must focus on previously-identified, well-characterized, candidate leads or lead candidate series and/or targets for the following select pathogen categories:

Vaccines 

Projects must focus on development of a candidate vaccine aligned with one of the following categories:

Multivalent/Universal Vaccines

Therapeutic Vaccines

Vaccines with Small Market Potential


Diagnostics 

Proposed diagnostics must align to one of the following programmatic diagnostic priorities:

Diagnostics that Facilitate Antibacterial Stewardship

Diagnostics for Zika Virus (ZIKV)


Budget - Budgets for direct costs of up to $750,000 per year may be requested.


Duration -  The maximum project period is 5 years.


Eligibility - Foreign (non-USA) Institutions are eligible to apply.


Deadline - October 3, 2016


Full details - http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-16-034.html 

Wednesday, March 9, 2016

Emerging Global Leader Award (K43)

The Fogarty Emerging Global Leader Award provides research support and protected time to a research scientist from a low- or middle-income country (LMIC) with a junior faculty position at an LMIC academic or research institution.  This intensive, mentored research career development experience is expected to lead to an independently funded research career. The award will provide salary and research project support.  Awardees are expected to increase their capabilities in advanced research methodology, analysis and data management, research administrative skills, responsible conduct of research, scientific presentation, publication and grants writing. 

Eligibility 

You must - 

  • be a researcher in a therapeutic or scientific area of health priority for Thailand 
  • have a full-time role with the Faculty 
  • not have residence or citizenship in the US or another high income country 
  • have at least a Master's, PhD is much preferred 
  • currently hold an academic junior (mid-level) faculty position or research scientist appointment 
  • have ( or be able to get) a mentor in the US and one in Thailand 
  • have not yet received independent grant funding 
  • have a clear project idea
  • demonstrate a commitment to a research career 
Duration 

Between 3 and 5 years 

Budget and support 

The award will  - 
  • pay salary and fringe benefits up to $75,000/year. (The salary must be consistent with salaries actually provided by the institution from its own funds)
  • contribute $30,000  per year toward the research development costs of the award recipient
Research development costs include, but are not limited to, supplies, equipment, technical personnel, tuition or registration fees for activities related to the proposed career development plan, fees for statistical and computational services, and travel to research sites, research meetings, or training

You will also receive the benefit of structured mentioning and career guidance 

Details 

Deadline - December 14, 2016;